Treatment strategies and clinical research progress of Hodgkin lymphoma
10.3760/cma.j.issn.1009-9921.2014.10.002
- VernacularTitle:霍奇金淋巴瘤的治疗共识及临床研究进展
- Author:
Qi MIN
;
Huaqing WANG
- Publication Type:Journal Article
- Keywords:
Hodgkin lymphoma;
Prognosis;
Treatment
- From:
Journal of Leukemia & Lymphoma
2014;23(10):581-582,585
- CountryChina
- Language:Chinese
-
Abstract:
Hodgkin lymphoma (HL) originates from the lymphoid hematopoietic tissues and has a good treatment outcome with relatively high cure rate.Early stage HL is curable with abbreviated chemotherapy plus involved-filed radiotherapy or chemotherapy alone.However,patients with refractory or relapsed disease still lack effective treatment.In recent years,with the application of risk stratified treatment,novel drugs such as brentuximad vedotin,and PET-CT evaluation,significant progress has been made in prognosis and treatment of HL